The Mood and Anxiety Disorders Program (MAP) is the world�s largest research program focused on mood
and anxiety disorders. Our nationally and internationally renowned clinical
researchers and basic scientists investigate the diagnosis, treatment and prevention
of serious mood and anxiety disorders. The program is divided into research
groups specializing in depression, bipolar disorder (manic‑depression), anxiety
disorders, posttraumatic stress disorder and obsessive compulsive disorder. We
have experts working with children, adolescents and adults. A broad range of methods is employed
including neurochemical, neuroendocrine, neurophysiological, and neuroimaging
to conduct studies into the causes and treatment of mood and anxiety
disorders. Our staff engage their
talent and spirit to carry out their mission; to contribute to the alleviation
of suffering by contributing to the discovery of new and improved treatments
for mood and anxiety disorders.
The past decade of mental health research has yielded
significant advances in both the diagnosis and treatment of mental disorders.
These advances could not have occurred without the participation of many patients and families.
We are indebted to those who have volunteered. Your participation
contributes to increased knowledge about mental illness in general and may
contribute to your own understanding of your condition. Medical evaluations,
consultations, procedures and treatments related to MAP research studies are
provided at no cost to you. MAP research is based on sound ethical principles
with a focus on compassionate care of research subjects and sensitive and
responsible follow-up and referral.
Treatment research is our highest priority. MAP physicians,
social workers, psychologists and nurses are whole-heartedly invested in
helping to lead the way to an improved quality of life for patients and their
families.